Severe sepsis Trials in St. Louis, United States
Conditions / Severe sepsis / St. Louis, United States
Severe sepsis has been the subject of sustained clinical investigation across multiple research sites.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01273779 | Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis | SUSPENDED | PHASE2/PHASE3 |
| NCT02576457 | Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis | TERMINATED | PHASE1 |
| NCT04353388 | Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington University | COMPLETED | — |
| NCT00334828 | ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis | COMPLETED | PHASE3 |
| NCT01598831 | Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy | COMPLETED | PHASE3 |
| NCT00630656 | Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis | COMPLETED | PHASE2 |
| NCT01280942 | Early Warning System for Clinical Deterioration on General Hospital Wards | COMPLETED | NA |
| NCT00386425 | Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) | COMPLETED | PHASE2 |
| NCT01319630 | The Effect of Three Different Fluids(Albumin 5%, Normal Saline, Hydroxyethyl Starch 130 kD) on Microcirculation in Severe Sepsis/Septic Shock Patients | COMPLETED | — |
| NCT02960854 | A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock. | COMPLETED | PHASE1 |